Literature DB >> 24016112

Polymeric nanoparticles for a drug delivery system.

Brian E Grottkau1, Xiaoxiao Cai, Jing Wang, Xingmei Yang, Yunfeng Lin.   

Abstract

In recent years, nanotechnology research has made great strides in the area of pharmacy, especially for drug delivery systems. Polymeric nanoparticles provide significant stability in anti-neoplastic drug research and have demonstrated the ability to solve the problems of therapeutic efficacy and diagnostic sensitivity. In this review, we describe the specific advantages of polymeric nanoparticles and their applications for a drug delivery system. The latest research on PHA-based polymeric nanoparticles and PLGA is also discussed.

Mesh：

Substances：

Year:  2013        PMID： 24016112     DOI： 10.2174/138920021131400105

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN： 1389-2002            Impact factor:   3.731


  14 in total

Review 1.  Nanodelivery of phytobioactive compounds for treating aging-associated disorders.

Authors:  Oleh Lushchak; Olha Strilbytska; Alexander Koliada; Alina Zayachkivska; Nadia Burdyliuk; Ihor Yurkevych; Kenneth B Storey; Alexander Vaiserman
Journal:  Geroscience       Date:  2019-11-04       Impact factor: 7.713

Review 2.  Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.

Authors:  Kye S Kim; Chul Gyu Song; Peter M Kang
Journal:  Antioxid Redox Signal       Date:  2018-01-30       Impact factor: 8.401

3.  Synthesis, physicochemical characterisation and biological activity of anandamide/ɛ-polycaprolactone nanoparticles obtained by electrospraying.

Authors:  Virna M Martín Giménez; Marcos G Russo; Griselda E Narda; Lucía B Fuentes; Luciana Mazzei; Carlos Gamarra-Luques; Diego E Kassuha; Walter Manucha
Journal:  IET Nanobiotechnol       Date:  2020-02       Impact factor: 1.847

4.  Simulation of the In Vivo Fate of Polymeric Nanoparticles Traced by Environment-Responsive Near-Infrared Dye: A Physiologically Based Pharmacokinetic Modelling Approach.

Authors:  Lei Li; Haisheng He; Sifang Jiang; Jianping Qi; Yi Lu; Ning Ding; Hai-Shu Lin; Wei Wu; Xiaoqiang Xiang
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

5.  In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters.

Authors:  Yun Hu; Marion Ehrich; Kristel Fuhrman; Chenming Zhang
Journal:  Nanoscale Res Lett       Date:  2014-08-27       Impact factor: 4.703

6.  Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials.

Authors:  Andrew Gdowski; Kaitlyn Johnson; Sunil Shah; Ignacy Gryczynski; Jamboor Vishwanatha; Amalendu Ranjan
Journal:  J Nanobiotechnology       Date:  2018-02-12       Impact factor: 10.435

Review 7.  Antileishmanial Activity of Amphotericin B-loaded-PLGA Nanoparticles: An Overview.

Authors:  Ernesto Palma; Antonella Pasqua; Agnese Gagliardi; Domenico Britti; Massimo Fresta; Donato Cosco
Journal:  Materials (Basel)       Date:  2018-07-09       Impact factor: 3.623

8.  Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties.

Authors:  Didier Betbeder; Emmanuelle Lipka; Mike Howsam; Rodolphe Carpentier
Journal:  Int J Nanomedicine       Date:  2015-08-26

9.  The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.

Authors:  Yuanyuan Xu; Ming Shen; Yiming Li; Ying Sun; Yanwei Teng; Yi Wang; Yourong Duan
Journal:  Oncotarget       Date:  2016-04-12

10.  Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery.

Authors:  M Costanzo; F Carton; A Marengo; G Berlier; B Stella; S Arpicco; M Malatesta
Journal:  Eur J Histochem       Date:  2016-04-14       Impact factor: 3.188
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.